Development of genetic systems for human-associated methanogens
人类相关产甲烷菌遗传系统的开发
基本信息
- 批准号:9019330
- 负责人:
- 金额:$ 18.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-15 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesArchaeaAtherosclerosisComplexDNADNA cassetteDataDevelopmentElectroporationEquipmentFermentationGene TargetingGeneticGenetic TranscriptionGenomicsGleanGoalsGrowthHealthHumanHuman ResourcesInflammatoryInflammatory Bowel DiseasesIntestinal CancerKnowledgeLinkLiposomesMalignant NeoplasmsMediatingMetabolicMethaneMethanobacteriaMethanobrevibacterMethodsNatureObesityOrganismOxygenPeriodontal DiseasesPersonal SatisfactionProcessResearchResistanceResourcesRoleSeriesSystemTechniquesTestingTransfectionbacterial resistancecytokinegenetic analysisgenetic manipulationhigh rewardhigh riskmanmembermethod developmentmicrobiotamicroorganismnext generation sequencingnutritionpan-genomepublic health relevanceresearch studyresistance genetooltranscriptome sequencingtranscriptomics
项目摘要
DESCRIPTION (provided by applicant): The goal of this high-risk/high-reward project is to develop the tools needed for experimental manipulation of human-associated methanogens. These commensal microorganisms colonize all humans, making significant contributions to host nutrition and overall health. The metabolic interactions between methanogens and other members of the human microbiota strongly influence the efficiency of the digestive process, as well as the colonic fermentation products that are absorbed by the host. Moreover, some human-associated methanogens are potent inducers of inflammatory cytokines, while others produce metabolites linked to the development of atherosclerosis and cancer. Given these observations, it is not surprising that methanogen carriage is correlated with a number of pathological conditions including obesity, inflammatory bowel disease, intestinal cancers and periodontal disease. Numerous hypotheses have been put forward to explain the linkage between methanogens and these health issues; unfortunately, experimental support for these ideas is exceedingly scarce. Three factors have contributed to this scarcity. First, all methanogens are exquisitely sensitive to oxygen and require specialized anaerobic techniques that are not widely employed; second, methods for genetic manipulation of human-associated methanogens are non-existent; and third, methanogen research has traditionally been restricted to the environmental and energy related topics. We propose to remedy this situation for the three of the dominant species of human-associated methanogens: Methanobrevibacter smithii, Methanospheara stadtmanae and the recently discovered Methanomassiliicoccus luminyensis. To achieve this goal we propose to develop genetic systems for human-associated methanogens and to acquire the genomic and transcriptomic resources needed to inform and direct the ongoing genetic analyses of these important microorganisms.
描述(由申请人提供):这个高风险/高回报项目的目标是开发人类相关产甲烷菌实验操作所需的工具。这些共生微生物寄生在全人类身上,为宿主的营养和整体健康做出了重大贡献。产甲烷菌和人类微生物群其他成员之间的代谢相互作用强烈影响消化过程的效率以及宿主吸收的结肠发酵产物。此外,一些与人类相关的产甲烷菌是炎症细胞因子的有效诱导剂,而另一些则产生与动脉粥样硬化和癌症发展相关的代谢物。鉴于这些观察结果,产甲烷菌携带与许多病理状况相关(包括肥胖、炎症性肠病、肠癌和牙周病)也就不足为奇了。人们提出了许多假设来解释产甲烷菌与这些健康问题之间的联系;不幸的是,这些想法的实验支持极其缺乏。三个因素造成了这种稀缺。首先,所有产甲烷菌都对氧气极其敏感,需要专门的厌氧技术,但目前尚未广泛采用;其次,不存在对人类相关产甲烷菌进行基因操作的方法;第三,产甲烷菌研究传统上仅限于环境和能源相关主题。我们建议针对人类相关产甲烷菌的三种主要物种:史密斯甲烷短杆菌(Methanobrevibacter smithii)、Stadtmanae 甲烷球菌(Methanospheara stadtmanae)和最近发现的发光甲烷甲烷菌(Methanomassiliicoccus luminyensis)来纠正这种情况。为了实现这一目标,我们建议开发与人类相关的产甲烷菌的遗传系统,并获取为这些重要微生物的持续遗传分析提供信息和指导所需的基因组和转录组资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM W METCALF其他文献
WILLIAM W METCALF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM W METCALF', 18)}}的其他基金
Discovery, biosynthesis and bioactivity of phosphonic acid natural products
膦酸天然产物的发现、生物合成及生物活性
- 批准号:
9900830 - 财政年份:2018
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, biosynthesis and bioactivity of phosphonic acid natural products
膦酸天然产物的发现、生物合成及生物活性
- 批准号:
10586384 - 财政年份:2018
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, Design, and Development of Phosphonic Acid Antibiotics
膦酸抗生素的发现、设计和开发
- 批准号:
7932615 - 财政年份:2009
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, Design, and Development of Phosphonic Acid Antibiotics
膦酸抗生素的发现、设计和开发
- 批准号:
8053862 - 财政年份:2007
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, Design, and Development of Phosphonic Acid Antibiotics
膦酸抗生素的发现、设计和开发
- 批准号:
7405438 - 财政年份:2007
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, Design, and Development of Phosphonic Acid Antibiotics
膦酸抗生素的发现、设计和开发
- 批准号:
7843654 - 财政年份:2007
- 资助金额:
$ 18.92万 - 项目类别:
DISCOVERY AND CHARACTERIZATION OF PHOSPHONIC ACID BIOSYNTHESIS PATHWAYS
膦酸生物合成途径的发现和表征
- 批准号:
7249591 - 财政年份:2007
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, Design, and Development of Phosphonic Acid Antibiotics
膦酸抗生素的发现、设计和开发
- 批准号:
8634110 - 财政年份:2007
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, Design, and Development of Phosphonic Acid Antibiotics
膦酸抗生素的发现、设计和开发
- 批准号:
8457035 - 财政年份:2007
- 资助金额:
$ 18.92万 - 项目类别:
Discovery, Design, and Development of Phosphonic Acid Antibiotics
膦酸抗生素的发现、设计和开发
- 批准号:
7619572 - 财政年份:2007
- 资助金额:
$ 18.92万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 18.92万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 18.92万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 18.92万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 18.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 18.92万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 18.92万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 18.92万 - 项目类别:














{{item.name}}会员




